Key facts
- It has raised $74.1M; the latest was Later Stage VC in Nov 2024.
- Notable investors include Sofinnova Partners, Arkin Capital, Indaco Venture Partners, VI Ventures, Accelmed — 15 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 15 names
- ·Watchlist + deal alerts for Pi-Cardia
- ·The full record, as it builds
Funding rounds
No funding rounds for Pi-Cardia are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Pi-Cardia
Developer of medical catheter technological device designed to offer treatment of aortic stenosis. The company's device is a trans-femoral catheter incorporating nitinol elements to create fractures in valve calcifications without injuring the surrounding soft tissues, enabling doctors to offer cost-effective and durable treatment.
- Sector
- Healthcare
- HQ
- Rehovot, Israel
- Founded
- 2009
- Employees
- 50
- Website
- pi-cardia.net/
- Ownership
- Privately Held (backing)
Pi-Cardia doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Pi-Cardia shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Pi-Cardia in its N-PORT filings yet. We sweep new filings monthly.